Get started
Author

Kenneth Stier

Observed name: KENNETH D. STIER
Institution: Yale University
ORCID: 0000-0003-4735-6314
Observed ORCID: 0000-0003-4735-6314
OpenAlex ID: A5080229684
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
2021 · Emily K. Sims, Brian N. Bundy, et al. · Science Translational Medicine · 374
PDF
Commercially available glutenases: a potential hazard in coeliac disease
2017 · Suneeta Krishnareddy, Kenneth Stier, et al. · Therapeutic Advances in Gastroenterology · 42
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
2020 · Ellinor Peerschke, Kenneth Stier, et al. · Frontiers in Oncology · 24
STAT signaling in the intestine
2021 · Yael R. Nobel, Kenneth Stier, et al. · International review of cytology · 11
277-OR: Teplizumab Reverses the Loss of C-Peptide in Relatives at Risk for Type 1 Diabetes (T1D)
2020 · EMILY K. SIMS, BRIAN N. BUNDY, et al. · Diabetes · 3
Research publication trends regarding the extraintestinal manifestations of celiac disease
2019 · Kenneth Stier, Suzanne K. Lewis, et al. · Informatics in Medicine Unlocked · 3
PDF
Works count: 6
Citation count: 457
H-index: 4
I10-index: 4
Year
Topic
Type